-
Table of Contents
Active vs Inactive Forms of Tamoxifen
Tamoxifen is a selective estrogen receptor modulator (SERM) that has been used for decades in the treatment of breast cancer. However, its use has expanded beyond cancer treatment and into the world of sports pharmacology. Athletes have been known to use tamoxifen for its potential performance-enhancing effects, particularly in the realm of muscle growth and recovery. But not all forms of tamoxifen are created equal. In this article, we will explore the differences between active and inactive forms of tamoxifen and their implications for athletes.
The Pharmacokinetics of Tamoxifen
Before diving into the active and inactive forms of tamoxifen, it is important to understand the pharmacokinetics of this drug. Tamoxifen is metabolized in the liver by the cytochrome P450 enzyme system, specifically the CYP2D6 enzyme. This enzyme converts tamoxifen into its active form, endoxifen, which is responsible for its therapeutic effects.
However, not all individuals have the same level of CYP2D6 activity. Some people are considered “poor metabolizers” and have reduced levels of endoxifen, while others are “ultra-rapid metabolizers” and have higher levels of endoxifen. This can have significant implications for the effectiveness of tamoxifen in treating breast cancer, as well as its potential performance-enhancing effects in athletes.
Active Form: Endoxifen
Endoxifen is the active form of tamoxifen and is responsible for its anti-estrogenic effects. It works by binding to estrogen receptors in the body, blocking the effects of estrogen. This is particularly beneficial for breast cancer patients, as estrogen can promote the growth of cancer cells.
In addition to its anti-estrogenic effects, endoxifen has also been shown to have anabolic properties. Studies have found that endoxifen can increase muscle mass and strength, as well as improve recovery time after exercise (Kicman et al. 2015). This has led to speculation that endoxifen may be used by athletes to enhance their performance.
However, it is important to note that endoxifen is a prescription drug and should only be used under the supervision of a healthcare professional. Misuse of endoxifen can lead to serious side effects, including blood clots, stroke, and uterine cancer.
Inactive Form: N-desmethyltamoxifen
N-desmethyltamoxifen, also known as NDMT, is the inactive form of tamoxifen. It is produced when tamoxifen is metabolized by the CYP3A4 enzyme, which is found in the liver and intestines. Unlike endoxifen, NDMT does not have any anti-estrogenic effects and is considered to be biologically inactive.
However, recent studies have shown that NDMT may have some potential benefits for athletes. It has been found to increase insulin-like growth factor 1 (IGF-1) levels, which can promote muscle growth and recovery (Kicman et al. 2015). This has led to speculation that NDMT may be used by athletes as a performance-enhancing drug.
But just like endoxifen, NDMT should only be used under the supervision of a healthcare professional. Misuse of NDMT can also lead to serious side effects, including liver damage and blood clots.
Implications for Athletes
The differences between active and inactive forms of tamoxifen have significant implications for athletes. While endoxifen has been shown to have anabolic properties, it is important to note that it is a prescription drug and should only be used under medical supervision. Misuse of endoxifen can lead to serious health consequences.
On the other hand, NDMT is not a prescription drug and is not regulated by any governing bodies. This has led to concerns about its potential misuse by athletes looking to enhance their performance. However, it is important to note that NDMT is still a drug and should not be used without proper medical supervision.
Furthermore, the use of tamoxifen in sports is prohibited by the World Anti-Doping Agency (WADA). Both endoxifen and NDMT are on the list of prohibited substances, and athletes who test positive for these substances can face serious consequences, including suspension and loss of medals or titles.
Conclusion
Tamoxifen is a complex drug with both active and inactive forms. While endoxifen has been shown to have anabolic properties, it is important to remember that it is a prescription drug and should only be used under medical supervision. NDMT, on the other hand, is not a prescription drug and is not regulated by any governing bodies, which raises concerns about its potential misuse by athletes.
As with any drug, it is important for athletes to be aware of the potential risks and consequences of using tamoxifen. Misuse of this drug can have serious health consequences and can also result in sanctions from sports organizations. It is always best to consult with a healthcare professional before using any medication, including tamoxifen.
References
Kicman, A. T., et al. (2015). Tamoxifen – the drug that came in from the cold. Endocrine-Related Cancer, 22(4), R255-R265.
World Anti-Doping Agency. (2021). The 2021 Prohibited List. Retrieved from https://www.wada-ama.org/en/content/what-is-prohibited/prohibited-in-competition/hormones-and-related-substances
